Details
| Stereochemistry | MIXED |
| Molecular Formula | C12H13NO3S3 |
| Molecular Weight | 315.432 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(SC(=O)C1=CC=CS1)C(=O)NC2CCSC2=O
InChI
InChIKey=MKTVMEMIKNBVHI-UHFFFAOYSA-N
InChI=1S/C12H13NO3S3/c1-7(19-12(16)9-3-2-5-17-9)10(14)13-8-4-6-18-11(8)15/h2-3,5,7-8H,4,6H2,1H3,(H,13,14)
| Molecular Formula | C12H13NO3S3 |
| Molecular Weight | 315.432 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Midesteine (previously known as MR 889), a thiolactic acid derivative was developed as an inhibitor of the chymotrypsin and elastolytic activity of leukocyte elastase. Midesteine participated in clinical trials for patients with chronic obstructive pulmonary disease. The drug is also studied to treat asthma, cystic fibrosis, and emphysema. However, all these studies were discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial. | 1996-07 |
|
| On the activity of MR 889, a new synthetic proteinase inhibitor. | 1991 |
|
| The kinetic mechanism of inhibition of human leukocyte elastase by MR889, a new cyclic thiolic compound. | 1990-03-01 |
|
| Studies of MR 889, a new synthetic proteinase inhibitor. | 1989-12-15 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8836663
Thirty subjects were administered MR889 orally at a dose of 500 mg b.i.d. for 4 weeks, and 30 received placebo following the same schedule.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:25:34 GMT 2025
by
admin
on
Mon Mar 31 19:25:34 GMT 2025
|
| Record UNII |
90K2YE9FTO
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL1808549
Created by
admin on Mon Mar 31 19:25:34 GMT 2025 , Edited by admin on Mon Mar 31 19:25:34 GMT 2025
|
PRIMARY | |||
|
C062051
Created by
admin on Mon Mar 31 19:25:34 GMT 2025 , Edited by admin on Mon Mar 31 19:25:34 GMT 2025
|
PRIMARY | |||
|
6572
Created by
admin on Mon Mar 31 19:25:34 GMT 2025 , Edited by admin on Mon Mar 31 19:25:34 GMT 2025
|
PRIMARY | |||
|
94149-41-4
Created by
admin on Mon Mar 31 19:25:34 GMT 2025 , Edited by admin on Mon Mar 31 19:25:34 GMT 2025
|
PRIMARY | |||
|
SUB08953MIG
Created by
admin on Mon Mar 31 19:25:34 GMT 2025 , Edited by admin on Mon Mar 31 19:25:34 GMT 2025
|
PRIMARY | |||
|
90K2YE9FTO
Created by
admin on Mon Mar 31 19:25:34 GMT 2025 , Edited by admin on Mon Mar 31 19:25:34 GMT 2025
|
PRIMARY | |||
|
DTXSID00869194
Created by
admin on Mon Mar 31 19:25:34 GMT 2025 , Edited by admin on Mon Mar 31 19:25:34 GMT 2025
|
PRIMARY | |||
|
100000080608
Created by
admin on Mon Mar 31 19:25:34 GMT 2025 , Edited by admin on Mon Mar 31 19:25:34 GMT 2025
|
PRIMARY | |||
|
C175137
Created by
admin on Mon Mar 31 19:25:34 GMT 2025 , Edited by admin on Mon Mar 31 19:25:34 GMT 2025
|
PRIMARY | |||
|
65837
Created by
admin on Mon Mar 31 19:25:34 GMT 2025 , Edited by admin on Mon Mar 31 19:25:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|